Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

PerSys Medical Earns FDA Clearance for the NIO Infant

PerSys Medical, a global leader in the development and marketing of innovative products for pre-hospital and hospital emergency medical situations, proudly announces today it has received US Food and Drug Administration (FDA) clearance for the NIO Infant.


News provided by

PerSys Medical

Nov 18, 2019, 09:00 ET

Share this article

Share toX

Share this article

Share toX

NIO Infant
NIO Infant

HOUSTON, Nov. 18, 2019 /PRNewswire-PRWeb/ -- PerSys Medical, a global leader in the development and marketing of innovative products for pre-hospital and hospital emergency medical situations, proudly announces today it has received US Food and Drug Administration (FDA) clearance for the NIO Infant.

The NIO Infant is a manual intraosseous (IO) access device that administers intravascular fluids and medications through the proximal tibia as an alternative to IV access during emergency medical situations. Its innovative stepped needle design allows for graduated penetration to the bone marrow cavity. Sensory feedback, in the form of resistance, indicates to the user that the needle is inserted correctly in the bone marrow cavity, thus preventing over penetration. The NIO™ Infant is a single-use, sterile device, eliminating the risk of cross contamination. It does not require batteries or an external power source, thereby making it a well-suited for hospital use, and the pre-hospital setting.

The NIO Infant is going to make it easier than ever for medical providers to gain vascular access, in what has been traditionally thought of as a challenging patient population. Dr. Mike Simpson"

Post this

"The first automatic intraosseous device was introduced by WaisMed Ltd, a subsidiary of the PerSys Medical, over two decades ago. It revolutionized the way intraosseous access was established during traumatic medical events" adds Roee Madai, CEO of WaisMed Ltd "After an arduous and comprehensive R&D process, we are excited to introduce the NIO Infant and offer a complete NIO product line for adult, pediatric, and infant populations."

WaisMed Ltd was founded in 1994 and acquired by PerSys Medical in 2004. WaisMed Ltd quickly established itself as a global leader in the intraosseous access market. In 1998, WaisMed Ltd brought to market the world's first automatic intraosseous access device, the Bone Injection Gun (B.I.G.). It launched an additional line of intraosseous devices, the NIO (Next Generation IO), in 2014.

The NIO Infant is a continuation of an elite line of vascular access devices which includes the NIO Adult, NIO Pediatric for children ages 3-12, and the NIO Simulation, the most realistic IO training device available. The NIO Adult provides rapid intraosseous (IO) access through the humeral head or tibia insertion site in 10 seconds or less. The NIO Pediatric provides rapid intraosseous (IO) access through the tibia insertion site.

Dr. Mike Simpson, Medical Director of PerSys Medical says, "I am extremely excited about what FDA clearance of our new NIO Infant means. This will be a huge step forward in capabilities to treat emergencies in patients less than three years of age. The NIO Infant is going to make it easier than ever for medical providers to gain vascular access, in what has been traditionally thought of as a challenging patient population."

PerSys Medical will begin commercial distribution of the NIO Infant in the US in the coming weeks.

About PerSys Medical Principal Products:
The Emergency Bandage®
The Emergency Bandage® is a sterile bandage with a unique built-in pressure bar that provides hemorrhage control and wound treatment in pre-hospital situations. The Emergency Bandage® has been proven effective in the combat as well as the EMS and civilian sector. It is also the only pressure bandage that is FDA approved as a non-pneumatic tourniquet.
The NIO – Next Generation IO
The NIO is a simple, automatic, intraosseous device that provides safe, quick, and easy vascular access in emergency situations for the administration of intravenous fluids and medications.
Blizzard Survival Products
Blizzard Protection Systems Ltd.'s line of products is made with Reflexcell™, a unique technology that was developed to reduce the risk of hypothermia and support patient treatment in extreme weather or suffering severe medical trauma. Blizzard Survival products are used globally by the military, EMS, and the private outdoors market.
Micro BVM
PerSys Medical offers a line of compact "pocket sized" collapsible bag valve masks (BVM). They are rugged, compact, are available in several variations. They also have a storage footprint that is 75% less compared with standard BVMs.
About PerSys Medical
PerSys Medical, a Texas based medical device company, is a global provider of emergency medical solutions designed for hospitals, militaries, first responders, civilians, and law-enforcement since the mid-90s. The company's commitment to research and development has brought to market innovations in intraosseous vascular access, hemorrhage control, hypothermia solutions, and airway management. With a strong corporate brand and superior products, PerSys Medical maintains a worldwide network of distributors and representatives serving more than 60 countries.
For more information about our products, visit: http://www.persysmedical.com
or LinkedIn http://bit.ly/2YeISsY

SOURCE PerSys Medical

Related Links

http://www.persysmedical.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.